Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …

Introduction: Vascular resection remains a subject of debate in the management of
Pancreatic Ductal Adenocarcinoma (PDAC). These French recommendations were drafted …

Objective: This study assesses the safety and outcomes of the largest cohort of
pancreatectomy with arterial resection (P-AR). Background: A high postoperative mortality …

Background Pancreatectomy with arterial resection (AR) is performed infrequently. As
indications evolve, we evaluated indications, outcomes, and predictors of mortality …

Classification and guidelines of hemorrhoidal disease are based on the subdivision in
Grades of prolapse followed by any aspect related to both the treatment and its technique …

Two areas that remain the focus of improvement in pancreatic cancer include high post-
operative morbidity and inability to uniformly translate surgical success into long-term …

Background En bloc celiac axis resection (CAR) for pancreatic cancer is considered
increasingly after modern neoadjuvant chemotherapy (NAC). Appleby and distal …

There is an evolving recognition that pancreatic cancer is a systemic disease at the time of
diagnosis, even among patients with apparent localized disease. As a result, and supported …

The anatomical structure of the pancreaticoduodenal region is complex and closely related
to the surrounding vessels. A variant of the hepatic artery, which is not a rare finding during …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a morbid malignancy with
discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation …